Cambria's Meb Faber dials in from sunny California to tell Alex and Frank all about betting the house on a biotech stock… and losing. Spoiler alert: options are involved. As are some classic investor misbehaviors including overconfidence, a lack of diversification, and poor (well, no) sell discipline.
But, as ever, we are here to learn and Meb explains how the multiple lessons from this one early error have shaped him into the investor he is today, not least by steering him away stock picking and toward to a quantitative approach.